Warren Shlomchik, MD, has been named Director of Stem Cell Transplantation and Cell Therapies for the University of Pittsburgh’s Division of Hematology-Oncology and the University of Pittsburgh Cancer Institute (UPCI). His appointment is effective March 1, 2015.
He also will serve as UPCI’s Scientific Director of Hematopoietic Malignancies, as well as Professor of Medicine and Immunology at the University of Pittsburgh School of Medicine.
Dr. Shlomchik previously served on the senior faculty at Yale Cancer Center at the Yale University School of Medicine.
Immunology Research
Dr. Shlomchik’s research has focused on the immunologic mechanisms underlying graft-vs-host disease (GVHD).
“Dr. Shlomchik’s work has been invaluable in helping researchers understand more about the mechanisms of GVHD,” said Edward Chu, MD, Chief of the Division of Hematology/Oncology and Deputy Director of UPCI. “His main priorities will be to continue to conduct innovative, groundbreaking laboratory-based science and to oversee the translation of that science into investigator-initiated clinical trials, which will be a huge advance for our transplant and hematopoietic malignancies clinical research program.” ■
